Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Savior Lifetec's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4167 vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Savior Lifetec's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savior Lifetec Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Savior Lifetec's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Savior Lifetec's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Savior Lifetec (ROCO:4167) has a Buyback Yield % of 2.17 as of Jul. 26, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Savior Lifetec and its competitors. According to the industry distribution chart, Savior Lifetec ranks #27 out of 738 companies in the Biotechnology industry, placing it in the top 3.7%.
Is Savior Lifetec's Buyback Yield % too high?
Savior Lifetec's current Buyback Yield % is 2.17. Based on the distribution chart, Savior Lifetec ranks #27 out of 738 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Savior Lifetec has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Savior Lifetec ranks #27 out of 738 companies for Buyback Yield %. This places Savior Lifetec in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Savior Lifetec and its competitors. Savior Lifetec's current Buyback Yield % is 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.30, compared to a current price of NT$20.60 — trading 1.5% above its estimated fair value. The current Buyback Yield % is 2.17. Savior Lifetec's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current Buyback Yield % is 2.17 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Savior Lifetec (ROCO:4167) Overvalued in 2026?
Based on GuruFocus' analysis, Savior Lifetec stock appears to be overvalued.
The current stock price of NT$20.60 is trading 1.5% above its estimated GF Value™ of NT$20.30.
GuruFocus considers Savior Lifetec to be Fairly Valued.
Key valuation signals for ROCO:4167:
Buyback Yield %: 2.17
GF Value™: NT$20.30 vs. price of NT$20.60 (1.5% above fair value)
No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
69GF Score
Get the complete analysis for ROCO:4167
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4167 has been successfully added to your 
